Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Study
![Weight-Loss Drug Wegovy Cuts Heart Risk in New Study](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Weight-Loss-Drug-Wegovy-Cuts-Heart-Risk-in-New-Study-400x400.jpeg)
Weight-Loss Drug Wegovy Cuts Heart Risk in New Study
- By nasdaqpicks.com
- . 8 August 2023
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
![Challenger wins United Auto Workers presidency vowing reforms By Reuters](http://www.nasdaqpicks.com/wp-content/uploads/2023/03/Challenger-wins-United-Auto-Workers-presidency-vowing-reforms-By-Reuters-400x400.jpg)
Canada’s CPKC signs deal to study passenger rail project in Mexico By Reuters
- By nasdaqpicks.com
- . 13 July 2023
© Reuters. MEXICO CITY (Reuters) – Mexico’s government and railroad company Canadian Pacific (NYSE:) Kansas City (CPKC) have formalized an agreement to study the viability
![ChatGPT's AI to power Chegg study buddy as educators wrestle with tech By Reuters](http://www.nasdaqpicks.com/wp-content/uploads/2023/04/ChatGPTs-AI-to-power-Chegg-study-buddy-as-educators-wrestle-400x400.jpg)
ChatGPT’s AI to power Chegg study buddy as educators wrestle with tech By Reuters
- By nasdaqpicks.com
- . 17 April 2023
© Reuters. FILE PHOTO: ChatGPT logo is seen in this illustration taken March 31, 2023. REUTERS/Dado Ruvic/Illustration By Jeffrey Dastin (Reuters) – The artificial intelligence
![US begins study of possible rules to regulate AI like ChatGPT By Reuters](http://www.nasdaqpicks.com/wp-content/uploads/2023/04/US-begins-study-of-possible-rules-to-regulate-AI-like-400x400.jpg)
US begins study of possible rules to regulate AI like ChatGPT By Reuters
- By nasdaqpicks.com
- . 11 April 2023
© Reuters. FILE PHOTO: ChatGPT logo is seen in this illustration taken, February 3, 2023. REUTERS/Dado Ruvic/Illustration/File Photo By David Shepardson and Diane Bartz WASHINGTON
![Freeport-McMoRan (FCX) Declares $0.08 Dividend](http://www.nasdaqpicks.com/wp-content/uploads/2023/03/Freeport-McMoRan-FCX-Declares-008-Dividend-400x400.jpg)
Australia to work with Germany on critical minerals study
- By nasdaqpicks.com
- . 6 April 2023
Adds details on the collaboration, background April 6 (Reuters) – Australia will team up with Germany to create new opportunities for the study of critical
![Bayer’s New American CEO to Study Wounded Pharma Giant Before Acting](http://www.nasdaqpicks.com/wp-content/uploads/2023/04/Bayers-New-American-CEO-to-Study-Wounded-Pharma-Giant-Before-400x400.jpeg)
Bayer’s New American CEO to Study Wounded Pharma Giant Before Acting
- By nasdaqpicks.com
- . 5 April 2023
Business Europe Bill Anderson aims to drive innovation and cultural change and lauds ‘compelling logic’ of Monsanto acquisition Source link
![A Case Study on the Power of Business Model Innovation](http://www.nasdaqpicks.com/wp-content/uploads/2023/03/A-Case-Study-on-the-Power-of-Business-Model-Innovation-400x400.jpg)
A Case Study on the Power of Business Model Innovation
- By nasdaqpicks.com
- . 31 March 2023
While there are many forms of innovation that a company can develop – such as product, process, network and customer experience innovation – business model innovation is
![](http://www.nasdaqpicks.com/wp-content/uploads/2023/03/STOCK-EXCHANGE-RUSSIAN-TRADING-SYSTEMS_800x533_L_1414427815-400x400.jpg)
U.S. labor force gap mostly due to pre-pandemic trends, study finds By Reuters
- By nasdaqpicks.com
- . 30 March 2023
© Reuters. FILE PHOTO: People walk on a street in New York, U.S., November 14, 2022. REUTERS/Eduardo Munoz/File Photo By Howard Schneider WASHINGTON (Reuters) –
![Freeport-McMoRan (FCX) Declares $0.08 Dividend](http://www.nasdaqpicks.com/wp-content/uploads/2023/03/Freeport-McMoRan-FCX-Declares-008-Dividend-400x400.jpg)
Biogen: BIIB080 Phase 1b Study Shows Reduction Of Tau PET Across Brain Regions
- By nasdaqpicks.com
- . 29 March 2023
(RTTNews) – Biogen Inc. (BIIB) reported Phase 1b clinical data showing that the investigational antisense oligonucleotide therapy, BIIB080, reduced soluble tau protein in cerebrospinal fluid